The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxi
As you advance in your scientific career, you may have the opportunity to transition from the bench
The idea behind gene therapy is to introduce, remove, or change a portion of person’s genetic code i
In this episode of ToxChats, Dr. Daniel Rudmann, an ACVP board-certified investigative and toxicolog
The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and securi
The toxicology salary survey began in 1988 to provide the profession with accurate salary informatio
Drug development targeted at pediatric populations has been the subject of a great deal of careful t
(CAR)T cells, also known as chimeric antigen receptor T cells, have transformed the landscape of can
Drs. Lisa Plitnick and Alan Stokes recently presented an ACT Signature Webinar titled “History and R
In this episode, Dr. Nicholas Ponzio, master educator and professor of pathology, immunology, and la
Dr. Thomas Hartung, is a professor at Johns Hopkins University and Director of the Center for Altern
In this episode, Dr. Doug Learn, Director of Toxicology at Charles River Safety Assessment in Horsha
In this interview, during the ACT 40th anniversary Annual Meeting in Phoenix, Arizona, plenary speak
In this episode, Dr. Armaghan Emami, a toxicologist with the Center for Drug Evaluation and Research
Dr. Jacob Corn, ACT’s 2015 Plenary Lecturer, is a Professor of Genome Biology at the Swiss Federal I
In this two-chapter episode, in vitro and alternative models for regulatory submissions were explore
In this episode, Dr. Arianne Motter, a toxicologist with the Center for Drug Evaluation and Research
In this episode of ToxChats, the opioid epidemic was discussed from a preclinical drug development p
The role of biomarkers and their qualification in nonclinical and clinical development is discussed
Dr. Rodney Dietert has authored a number of books on the immune system and extensively published on
Oligonucleotide therapeutics are all medications that utilize RNA- or DNA-based techniques as the ef
